Literature DB >> 20647424

Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Giulio Genovese1, David J Friedman, Michael D Ross, Laurence Lecordier, Pierrick Uzureau, Barry I Freedman, Donald W Bowden, Carl D Langefeld, Taras K Oleksyk, Andrea L Uscinski Knob, Andrea J Bernhardy, Pamela J Hicks, George W Nelson, Benoit Vanhollebeke, Cheryl A Winkler, Jeffrey B Kopp, Etienne Pays, Martin R Pollak.   

Abstract

African Americans have higher rates of kidney disease than European Americans. Here, we show that, in African Americans, focal segmental glomerulosclerosis (FSGS) and hypertension-attributed end-stage kidney disease (H-ESKD) are associated with two independent sequence variants in the APOL1 gene on chromosome 22 {FSGS odds ratio = 10.5 [95% confidence interval (CI) 6.0 to 18.4]; H-ESKD odds ratio = 7.3 (95% CI 5.6 to 9.5)}. The two APOL1 variants are common in African chromosomes but absent from European chromosomes, and both reside within haplotypes that harbor signatures of positive selection. ApoL1 (apolipoprotein L-1) is a serum factor that lyses trypanosomes. In vitro assays revealed that only the kidney disease-associated ApoL1 variants lysed Trypanosoma brucei rhodesiense. We speculate that evolution of a critical survival factor in Africa may have contributed to the high rates of renal disease in African Americans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20647424      PMCID: PMC2980843          DOI: 10.1126/science.1193032

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  23 in total

Review 1.  Human red blood cell polymorphisms and malaria.

Authors:  Thomas N Williams
Journal:  Curr Opin Microbiol       Date:  2006-07-03       Impact factor: 7.934

Review 2.  Will the real Trypanosoma brucei rhodesiense please step forward?

Authors:  Wendy Gibson
Journal:  Trends Parasitol       Date:  2002-11

3.  Apolipoprotein L-I is the trypanosome lytic factor of human serum.

Authors:  Luc Vanhamme; Françoise Paturiaux-Hanocq; Philippe Poelvoorde; Derek P Nolan; Laurence Lins; Jan Van Den Abbeele; Annette Pays; Patricia Tebabi; Huang Van Xong; Alain Jacquet; Nicole Moguilevsky; Marc Dieu; John P Kane; Patrick De Baetselier; Robert Brasseur; Etienne Pays
Journal:  Nature       Date:  2003-03-06       Impact factor: 49.962

Review 4.  Positive natural selection in the human lineage.

Authors:  P C Sabeti; S F Schaffner; B Fry; J Lohmueller; P Varilly; O Shamovsky; A Palma; T S Mikkelsen; D Altshuler; E S Lander
Journal:  Science       Date:  2006-06-16       Impact factor: 47.728

5.  Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.

Authors:  Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Cunningham; Yongmei Liu; Jasmin Divers; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

Review 6.  Genetic factors in end-stage renal disease.

Authors:  Scott G Satko; Barry I Freedman; Shahriar Moossavi
Journal:  Kidney Int Suppl       Date:  2005-04       Impact factor: 10.545

7.  Will the real Trypanosoma b. gambiense please stand up.

Authors:  W C Gibson
Journal:  Parasitol Today       Date:  1986-09

8.  A second generation human haplotype map of over 3.1 million SNPs.

Authors:  Kelly A Frazer; Dennis G Ballinger; David R Cox; David A Hinds; Laura L Stuve; Richard A Gibbs; John W Belmont; Andrew Boudreau; Paul Hardenbol; Suzanne M Leal; Shiran Pasternak; David A Wheeler; Thomas D Willis; Fuli Yu; Huanming Yang; Changqing Zeng; Yang Gao; Haoran Hu; Weitao Hu; Chaohua Li; Wei Lin; Siqi Liu; Hao Pan; Xiaoli Tang; Jian Wang; Wei Wang; Jun Yu; Bo Zhang; Qingrun Zhang; Hongbin Zhao; Hui Zhao; Jun Zhou; Stacey B Gabriel; Rachel Barry; Brendan Blumenstiel; Amy Camargo; Matthew Defelice; Maura Faggart; Mary Goyette; Supriya Gupta; Jamie Moore; Huy Nguyen; Robert C Onofrio; Melissa Parkin; Jessica Roy; Erich Stahl; Ellen Winchester; Liuda Ziaugra; David Altshuler; Yan Shen; Zhijian Yao; Wei Huang; Xun Chu; Yungang He; Li Jin; Yangfan Liu; Yayun Shen; Weiwei Sun; Haifeng Wang; Yi Wang; Ying Wang; Xiaoyan Xiong; Liang Xu; Mary M Y Waye; Stephen K W Tsui; Hong Xue; J Tze-Fei Wong; Luana M Galver; Jian-Bing Fan; Kevin Gunderson; Sarah S Murray; Arnold R Oliphant; Mark S Chee; Alexandre Montpetit; Fanny Chagnon; Vincent Ferretti; Martin Leboeuf; Jean-François Olivier; Michael S Phillips; Stéphanie Roumy; Clémentine Sallée; Andrei Verner; Thomas J Hudson; Pui-Yan Kwok; Dongmei Cai; Daniel C Koboldt; Raymond D Miller; Ludmila Pawlikowska; Patricia Taillon-Miller; Ming Xiao; Lap-Chee Tsui; William Mak; You Qiang Song; Paul K H Tam; Yusuke Nakamura; Takahisa Kawaguchi; Takuya Kitamoto; Takashi Morizono; Atsushi Nagashima; Yozo Ohnishi; Akihiro Sekine; Toshihiro Tanaka; Tatsuhiko Tsunoda; Panos Deloukas; Christine P Bird; Marcos Delgado; Emmanouil T Dermitzakis; Rhian Gwilliam; Sarah Hunt; Jonathan Morrison; Don Powell; Barbara E Stranger; Pamela Whittaker; David R Bentley; Mark J Daly; Paul I W de Bakker; Jeff Barrett; Yves R Chretien; Julian Maller; Steve McCarroll; Nick Patterson; Itsik Pe'er; Alkes Price; Shaun Purcell; Daniel J Richter; Pardis Sabeti; Richa Saxena; Stephen F Schaffner; Pak C Sham; Patrick Varilly; David Altshuler; Lincoln D Stein; Lalitha Krishnan; Albert Vernon Smith; Marcela K Tello-Ruiz; Gudmundur A Thorisson; Aravinda Chakravarti; Peter E Chen; David J Cutler; Carl S Kashuk; Shin Lin; Gonçalo R Abecasis; Weihua Guan; Yun Li; Heather M Munro; Zhaohui Steve Qin; Daryl J Thomas; Gilean McVean; Adam Auton; Leonardo Bottolo; Niall Cardin; Susana Eyheramendy; Colin Freeman; Jonathan Marchini; Simon Myers; Chris Spencer; Matthew Stephens; Peter Donnelly; Lon R Cardon; Geraldine Clarke; David M Evans; Andrew P Morris; Bruce S Weir; Tatsuhiko Tsunoda; James C Mullikin; Stephen T Sherry; Michael Feolo; Andrew Skol; Houcan Zhang; Changqing Zeng; Hui Zhao; Ichiro Matsuda; Yoshimitsu Fukushima; Darryl R Macer; Eiko Suda; Charles N Rotimi; Clement A Adebamowo; Ike Ajayi; Toyin Aniagwu; Patricia A Marshall; Chibuzor Nkwodimmah; Charmaine D M Royal; Mark F Leppert; Missy Dixon; Andy Peiffer; Renzong Qiu; Alastair Kent; Kazuto Kato; Norio Niikawa; Isaac F Adewole; Bartha M Knoppers; Morris W Foster; Ellen Wright Clayton; Jessica Watkin; Richard A Gibbs; John W Belmont; Donna Muzny; Lynne Nazareth; Erica Sodergren; George M Weinstock; David A Wheeler; Imtaz Yakub; Stacey B Gabriel; Robert C Onofrio; Daniel J Richter; Liuda Ziaugra; Bruce W Birren; Mark J Daly; David Altshuler; Richard K Wilson; Lucinda L Fulton; Jane Rogers; John Burton; Nigel P Carter; Christopher M Clee; Mark Griffiths; Matthew C Jones; Kirsten McLay; Robert W Plumb; Mark T Ross; Sarah K Sims; David L Willey; Zhu Chen; Hua Han; Le Kang; Martin Godbout; John C Wallenburg; Paul L'Archevêque; Guy Bellemare; Koji Saeki; Hongguang Wang; Daochang An; Hongbo Fu; Qing Li; Zhen Wang; Renwu Wang; Arthur L Holden; Lisa D Brooks; Jean E McEwen; Mark S Guyer; Vivian Ota Wang; Jane L Peterson; Michael Shi; Jack Spiegel; Lawrence M Sung; Lynn F Zacharia; Francis S Collins; Karen Kennedy; Ruth Jamieson; John Stewart
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

9.  Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection.

Authors:  Marie Samanovic; Maria Pilar Molina-Portela; Anne-Danielle C Chessler; Barbara A Burleigh; Jayne Raper
Journal:  PLoS Pathog       Date:  2009-01-23       Impact factor: 6.823

Review 10.  Eliminating human African trypanosomiasis: where do we stand and what comes next?

Authors:  Pere P Simarro; Jean Jannin; Pierre Cattand
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

View more
  905 in total

1.  GLCCI1 single nucleotide polymorphisms in pediatric nephrotic syndrome.

Authors:  Hae Il Cheong; Hee Gyung Kang; Johannes Schlondorff
Journal:  Pediatr Nephrol       Date:  2012-06-04       Impact factor: 3.714

2.  Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children.

Authors:  Patricio E Ray; Chien-An A Hu
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

3.  Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107.

Authors:  Kuixing Zhang; Saiful A Mir; C Makena Hightower; Jose Pablo Miramontes-Gonzalez; Adam X Maihofer; Yuqing Chen; Sushil K Mahata; Caroline M Nievergelt; Nicholas J Schork; Barry I Freedman; Sucheta M Vaingankar; Daniel T O'Connor
Journal:  J Am Soc Nephrol       Date:  2014-11-12       Impact factor: 10.121

4.  Chronic kidney disease and risk of renal cell carcinoma: differences by race.

Authors:  Jonathan N Hofmann; Douglas A Corley; Wei K Zhao; Joanne S Colt; Brian Shuch; Wong-Ho Chow; Mark P Purdue
Journal:  Epidemiology       Date:  2015-01       Impact factor: 4.822

5.  Renal cancer paradox: higher incidence but not higher mortality among African-Americans.

Authors:  Loren Lipworth; Joseph K McLaughlin; Robert E Tarone; William J Blot
Journal:  Eur J Cancer Prev       Date:  2011-07       Impact factor: 2.497

6.  APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8.

Authors:  Sethu M Madhavan; John F O'Toole; Martha Konieczkowski; Laura Barisoni; David B Thomas; Santhi Ganesan; Leslie A Bruggeman; Matthias Buck; John R Sedor
Journal:  JCI Insight       Date:  2017-07-20

7.  Complement factor H gene associations with end-stage kidney disease in African Americans.

Authors:  Jason A Bonomo; Nicholette D Palmer; Pamela J Hicks; Janice P Lea; Mark D Okusa; Carl D Langefeld; Donald W Bowden; Barry I Freedman
Journal:  Nephrol Dial Transplant       Date:  2014-02-28       Impact factor: 5.992

Review 8.  Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.

Authors:  Oleh Akchurin; Kimberly J Reidy
Journal:  Pediatr Nephrol       Date:  2014-03-02       Impact factor: 3.714

9.  JC viruria and kidney disease in APOL1 risk genotype individuals: is this a clue to a gene × environment interaction?

Authors:  Jeffrey B Kopp
Journal:  Kidney Int       Date:  2013-12       Impact factor: 10.612

10.  Perceptions regarding genetic testing in populations at risk for nephropathy.

Authors:  Barry I Freedman; Alison J Fletcher; Vivek R Sanghani; Mitzie Spainhour; Angelina W Graham; Gregory B Russell; Jessica N Cooke Bailey; Ana S Iltis; Nancy M P King
Journal:  Am J Nephrol       Date:  2013-11-21       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.